🔎 Trials Near Me

Inicio › Fallo cardíaco › Colorado

Ensayos clínicos de Fallo cardíaco en Colorado

23 estudios sobre Fallo cardíaco buscan participantes en Colorado.

Ciudades en Colorado

Texto oficial del estudio (inglés)

A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF

  • Research Site, Colorado Springs
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 28 sept 2026 · NCT07761117

Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction

  • Rocky Mountain Regional VA Medical Center, Aurora
ReclutandoFase 3
Edades de 18 a 85 · Todos los sexos · Actualizado el 24 sept 2026 · NCT06736574

Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin

  • Research Site, Aurora
  • Research Site, Englewood
ReclutandoFase 3
Edades de 40 en adelante · Todos los sexos · Actualizado el 15 sept 2026 · NCT06677060

Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function

  • Research Site, Aurora
ReclutandoFase 3
Edades de 18 a 130 · Todos los sexos · Actualizado el 11 sept 2026 · NCT06307652

A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients

  • Aurora, CO Investigative Site 10001, Aurora
  • Denver, CO Investigative Site 10005, Denver
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 10 sept 2026 · NCT06008197

A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)

  • CON-10001, Aurora, CO, Aurora
  • CON-10005, Denver, CO, Denver
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 10 sept 2026 · NCT06024746

Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)

  • Children's Hospital Colorado ( Site 0012), Aurora
ReclutandoFase 2/3
29 Days – 17 Years · Todos los sexos · Actualizado el 28 ago 2026 · NCT05714085

Optimizing Heart Failure Therapies Among Patients With Limited Access in Denver

  • Denver Health and Hospital Authority, Denver
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 26 ago 2026 · NCT07435662

Optimal Pediatric Heart Transplant Immunosuppression With MicroRNAs

  • Children's Hospital Colorado, Aurora
ReclutandoEstudio observacional
Hasta los 18 · Todos los sexos · Actualizado el 25 ago 2026 · NCT06532890

Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products

  • Aurora
  • Centennial
  • Colorado Springs
  • y 1 más
ReclutandoEstudio observacional
Todas las edades · Todos los sexos · Actualizado el 20 ago 2026 · NCT00271180

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

  • Univ of Colorado at Denver, Aurora
  • VA Eastern Colorado Health Care System, Aurora
  • Intermountain Heart & Vascular, Denver
  • y 1 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 18 ago 2026 · NCT07567001

Implementation and Interaction of Clinician And Patient-facing Tools Aiming to Intensify Neurohormonal Medicines for Heart Failure

  • University of Colorado, Aurora
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 13 jul 2026 · NCT06526988

A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists

  • FIN-10110, Aurora, CO, Aurora
  • FIN-10001, Aurora, CO, Aurora
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 10 jul 2026 · NCT06033950

A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction

  • Children's Hospital Colorado - Anschutz Medical Campus - Cardiology, Aurora
ReclutandoFase 3
Hasta los 18 · Todos los sexos · Actualizado el 29 jun 2026 · NCT07192952

A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction

  • Children's Hospital Colorado - Anschutz Medical Campus - Cardiology, Aurora
ReclutandoFase 3
6 Months – 17 Years · Todos los sexos · Actualizado el 15 jun 2026 · NCT07188805

Observational Study of Patients Undergoing Diagnostic Right Heart Catheterization

  • Boulder Heart, Boulder
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 13 abr 2026 · NCT07224906

The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR

  • South Denver Cardiology, Littleton
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 13 abr 2026 · NCT03142152

Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease

  • Barbara Davis Center / University of Colorado Denver, Aurora
ReclutandoFase 3
Edades de 18 a 75 · Todos los sexos · Actualizado el 24 mar 2026 · NCT06217302

Left vs Left Randomized Clinical Trial

  • University of Colorado (Anschutz Medical Campus), Denver
  • South Denver Cardiology Associates, Littleton
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 2 oct 2025 · NCT05650658

Open-label, Dose Escalation Study of Safety and Preliminary Efficacy of TN-401 in Adults With PKP2 Mutation-associated ARVC

  • University of Colorado - Anschutz Medical Campus, Aurora
ReclutandoFase 1
Edades de 18 a 65 · Todos los sexos · Actualizado el 6 feb 2025 · NCT06228924

De ClinicalTrials.gov, datos obtenidos el 30 sept 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.